Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use. Can Diabetes Endocrinol Today. 2023;1(3):21–26. doi:10.58931/cdet.2023.1318